 |
Obatoclax mesylate |
|---|---|
| Trade Name | |
| Orphan Indication | Myelofibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2006-12-01 00:00:00 |
| Sponsor | Gemin X Pharmaceuticals US, Inc.;400 Chesterfield Pkwy., Suite 100;Malvern, Pennsylvania, 19355 |
Related Access Program